• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

左前臂重排肉瘤的临床病理分析:一例报告

Clinicopathological analysis of rearranged sarcoma in the left forearm: A case report.

作者信息

Hu Qiao-Ling, Zeng Chao

机构信息

Department of Pathology, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518000, Guangdong Province, China.

出版信息

World J Clin Cases. 2024 Jun 6;12(16):2887-2893. doi: 10.12998/wjcc.v12.i16.2887.

DOI:10.12998/wjcc.v12.i16.2887
PMID:38899283
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11185342/
Abstract

BACKGROUND

We present a case of an rearranged sarcoma in the left forearm and analyze its clinicopathological and molecular features.

CASE SUMMARY

The patient is a 23-year-old woman. Microscopically, the tumor cells were medium-sized round cells arranged in small nests. The cytoplasm was clear, nuclei were relatively uniform, chromatin was dense, nucleoli were visible, and mitotic figures were rare. Immunohistochemically, the tumor cells were positive for Vimentin, INI-1, CD99, NKX2.2, CyclinD1, friend leukaemia virus integration 1, and NKX3.1. Next-generation sequencing revealed the presence of the fusion gene. rearranged sarcomas are rare and can easily be misdiagnosed.

CONCLUSION

Clinical imaging, immunohistochemistry, and molecular pathology should be considered to confirm the diagnosis.

摘要

背景

我们报告一例左前臂重排肉瘤病例,并分析其临床病理和分子特征。

病例摘要

患者为一名23岁女性。显微镜下,肿瘤细胞为中等大小的圆形细胞,呈小巢状排列。细胞质清晰,细胞核相对均匀,染色质致密,可见核仁,有丝分裂象罕见。免疫组化显示,肿瘤细胞波形蛋白、INI-1、CD99、NKX2.2、细胞周期蛋白D1、Friend白血病病毒整合1和NKX3.1呈阳性。二代测序显示存在融合基因。重排肉瘤罕见,易被误诊。

结论

应考虑通过临床影像学、免疫组化和分子病理学来确诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7e/11185342/81048562533f/WJCC-12-2887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7e/11185342/a5c53163a700/WJCC-12-2887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7e/11185342/efab4b06bacb/WJCC-12-2887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7e/11185342/81048562533f/WJCC-12-2887-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7e/11185342/a5c53163a700/WJCC-12-2887-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7e/11185342/efab4b06bacb/WJCC-12-2887-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf7e/11185342/81048562533f/WJCC-12-2887-g003.jpg

相似文献

1
Clinicopathological analysis of rearranged sarcoma in the left forearm: A case report.左前臂重排肉瘤的临床病理分析:一例报告
World J Clin Cases. 2024 Jun 6;12(16):2887-2893. doi: 10.12998/wjcc.v12.i16.2887.
2
Report and literature review of four cases of EWSR1::NFATC2 round cell sarcoma.报告并文献复习 4 例 EWSR1::NFATC2 圆形细胞肉瘤。
Diagn Pathol. 2024 Jan 22;19(1):19. doi: 10.1186/s13000-024-01443-y.
3
EWSR1/FUS-NFATc2 rearranged round cell sarcoma: clinicopathological series of 4 cases and literature review.EWSR1/FUS-NFATc2 重排的圆形细胞肉瘤:4 例临床病理系列及文献复习。
Hum Pathol. 2019 Aug;90:45-53. doi: 10.1016/j.humpath.2019.05.001. Epub 2019 May 9.
4
Clinicopathological Features of Three Rare Sarcomas of Bone and Soft Tissues.三种罕见的骨和软组织肉瘤的临床病理特征。
Int J Surg Pathol. 2024 Oct;32(7):1275-1285. doi: 10.1177/10668969241228294. Epub 2024 Feb 6.
5
NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.NKX3-1 是 EWSR1-NFATC2 肉瘤和间叶性软骨肉瘤的有用免疫组化标志物。
Am J Surg Pathol. 2020 Jun;44(6):719-728. doi: 10.1097/PAS.0000000000001441.
6
Implementation of Copy Number Variations-Based Diagnostics in Morphologically Challenging Neoplasms of the Bone and Soft Tissue.基于拷贝数变异的诊断在形态学具有挑战性的骨和软组织肿瘤中的应用。
Int J Mol Sci. 2022 Dec 19;23(24):16196. doi: 10.3390/ijms232416196.
7
Identification of EWSR1-NFATC2 fusion in simple bone cysts.鉴定单纯性骨囊肿中的 EWSR1-NFATC2 融合。
Histopathology. 2021 May;78(6):849-856. doi: 10.1111/his.14314. Epub 2021 Mar 16.
8
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.NFATc2 重排肉瘤:7 例伴有新型诊断标志物 Aggrecan 证据的临床病理、分子和细胞遗传学研究。
Mod Pathol. 2020 Oct;33(10):1930-1944. doi: 10.1038/s41379-020-0542-z. Epub 2020 Apr 23.
9
The diagnostic utility of cytology specimen in a case of EWSR1::NFATC2 sarcoma.在 EWSR1::NFATC2 肉瘤病例中细胞学标本的诊断效用。
Virchows Arch. 2024 Mar;484(3):533-538. doi: 10.1007/s00428-024-03784-x. Epub 2024 Mar 14.
10
and Gene Fusion-Associated Mesenchymal Tumors: Clinicopathologic Correlation and Literature Review.以及基因融合相关的间充质肿瘤:临床病理相关性及文献综述
Sarcoma. 2019 Mar 26;2019:9386390. doi: 10.1155/2019/9386390. eCollection 2019.

本文引用的文献

1
Extraskeletal myxoid chondrosarcoma: p53 and Ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.骨外黏液样软骨肉瘤:p53 和 Ki-67 对临床结局具有预后价值——31 例病例的免疫组化和分子分析。
Virchows Arch. 2023 Feb;482(2):407-417. doi: 10.1007/s00428-022-03453-x. Epub 2022 Nov 14.
2
A group of sclerosing epithelioid fibrosarcomas with low-level amplified EWSR1-CREB3L1 fusion gene in children.一组儿童中具有低水平扩增EWSR1-CREB3L1融合基因的硬化性上皮样纤维肉瘤
Pathol Res Pract. 2022 Feb;230:153754. doi: 10.1016/j.prp.2021.153754. Epub 2021 Dec 30.
3
Skeletal EWSR1-NFATC2 sarcoma previously diagnosed as Ewing-like adamantinoma: A case report and literature review emphasizing its unique radiological features.
先前被诊断为尤因样釉质瘤的骨骼EWSR1-NFATC2肉瘤:病例报告及文献综述,着重介绍其独特的放射学特征
Pathol Int. 2021 Sep;71(9):614-620. doi: 10.1111/pin.13135. Epub 2021 Jun 30.
4
Multiscale-omic assessment of EWSR1-NFATc2 fusion positive sarcomas identifies the mTOR pathway as a potential therapeutic target.EWSR1-NFATc2融合阳性肉瘤的多尺度组学评估确定mTOR通路为潜在治疗靶点。
NPJ Precis Oncol. 2021 May 21;5(1):43. doi: 10.1038/s41698-021-00177-0.
5
Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network.利用专家病理审查网络,四年间全国范围内的中间恶性肉瘤和结缔组织肿瘤的发病率。
PLoS One. 2021 Feb 25;16(2):e0246958. doi: 10.1371/journal.pone.0246958. eCollection 2021.
6
NKX3.1 a useful marker for mesenchymal chondrosarcoma: An immunohistochemical study.NKX3.1:间叶性软骨肉瘤的一种有用标志物——一项免疫组织化学研究
Ann Diagn Pathol. 2021 Feb;50:151660. doi: 10.1016/j.anndiagpath.2020.151660. Epub 2020 Nov 5.
7
Extraskeletal Myxoid Chondrosarcoma: State of the Art and Current Research on Biology and Clinical Management.骨外黏液样软骨肉瘤:生物学与临床管理的最新进展及当前研究
Cancers (Basel). 2020 Sep 21;12(9):2703. doi: 10.3390/cancers12092703.
8
Sclerosing Epithelioid Fibrosarcoma: A Distinct Sarcoma With Aggressive Features.硬化性上皮样纤维肉瘤:一种具有侵袭性特征的独特肉瘤。
Am J Surg Pathol. 2021 Mar 1;45(3):317-328. doi: 10.1097/PAS.0000000000001559.
9
NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker.NFATc2 重排肉瘤:7 例伴有新型诊断标志物 Aggrecan 证据的临床病理、分子和细胞遗传学研究。
Mod Pathol. 2020 Oct;33(10):1930-1944. doi: 10.1038/s41379-020-0542-z. Epub 2020 Apr 23.
10
NKX3-1 Is a Useful Immunohistochemical Marker of EWSR1-NFATC2 Sarcoma and Mesenchymal Chondrosarcoma.NKX3-1 是 EWSR1-NFATC2 肉瘤和间叶性软骨肉瘤的有用免疫组化标志物。
Am J Surg Pathol. 2020 Jun;44(6):719-728. doi: 10.1097/PAS.0000000000001441.